HealthTech
Samsung invests $110M in healthcare firm GRAIL to expand cancer test into Korea, Asia
The United States-based healthcare firm GRAIL has closed an equity financing deal in which Samsung affiliates, including Samsung C&T Corporation, invested $110 million through the purchase of GRAIL common stock at $70.05 per share.
Australia’s medtech Ovum raises $4M to build AI infrastructure for women
Ovum, an Australian women's health company founded by Ariella Heffernan-Marks, has raised $4 million in seed funding to address the gender health gap, tripling its valuation just one year after securing $1.7 million in a pre-seed round.
Japan’s Murata Tribe launch MedTech open innovation program for ASEAN and India startups
Japan's Murata Electronics and Signapore-based Tribe, an open innovation platform, have launched KUMIHIMO Tech Camp Singapore 2026, an open innovation programme inviting MedTech startups across ASEAN and India to co-develop healthcare solutions addressing the region's most pressing medical challenges.
I.W.G’s Xiaoyan (Fiona) Zhou on how AI can help connect fragmented healthcare systems across Asia [Q&A]
As hospitals, clinics, insurers, and healthcare partners across Asia digitize their operations, the harder challenge is making medical data usable across fragmented systems and borders. In this Q&A, Xiaoyan (Fiona) Zhou of I.W.G shares her perspective on healthcare interoperability, AI-enabled referral coordination, cross-border medical data exchange, and…
CapitaLand officially opens $1.09B life sciences and innovation hub at Singapore
Singapore's property firm CapitaLand Group (CapitaLand) has on Friday officially opened Geneo, a life sciences and innovation hub at Singapore Science Park (SSP) with about S$1.4 billion ($1.09 billion) investments.
Convergence in the blood: How AI and biotech are rewriting cancer detection across Asia
Industrial bases, not just science, will determine whether breakthroughs become real benefits.
Singapore’s Brano Therapeutics raises $6.8M seed funding to advance heart failure treatments
Brano Therapeutics, a spin-off from Singapore's Duke-NUS Medical School, has secured $6.8 million in seed funding to support the development of new treatments for heart failure, including heart failure with preserved ejection fraction (HFpEF), a condition with limited therapeutic options.
Singapore healthcare firm UltraGreen.ai secures approval for Verdye surgery
UltraGreen.ai Limited (SGX: ULG) has received regulatory approval in Singapore for Verdye, an indocyanine green (ICG) injection used in fluorescence-guided surgery.
Ekuinas acquires strategic minority stake in Malaysia’s pharmaceutical firm Ain Medicare
Ekuiti Nasional Berhad (Ekuinas) announced Tuesday its investment in Ain Medicare Sdn Bhd, a Bumiputera home-grown manufacturer of sterile parenteral pharmaceutical products.
